Glenn Greenberg Holdings Activity

Brave Warrior Advisors Portfolio 13F

Brave Warrior Advisors has disclosed a total of 26 changes to the portfolio in the latest (2025 Q2) SEC report(s): increased the number of shares of 8, bought 3 totally new, decreased the number of shares of 12 and completely sold out 3 position(s).

What stocks is Glenn Greenberg buying now?

In the recent quarter Glenn Greenberg has bought 11 securities out of which top 5 purchases (by % change to portfolio) are (COF) CAPITAL ONE FINANCIAL CORP (added shares +190.24%), (BLDR) BUILDERS FIRSTSOURCE INC (added shares +47.17%), (SLM) SLM CORP (added shares +11.48%), (OMF) ONEMAIN HOLDINGS INC (added shares +7.17%) and (AN) AUTONATION INC (added shares +7.47%).

What does Glenn Greenberg invest in?

Glenn Greenberg's top 5 holdings (by % of portfolio) are (SNX) SYNNEX CORP (11.72%), (OMF) ONEMAIN HOLDINGS INC (10.28%), (ANTM) ANTHEM INC (9.89%), (COF) CAPITAL ONE FINANCIAL CORP (8.94%) and (SLM) SLM CORP (7.92%).

In the latest report(s) the following changes have been made to the top investments: (SNX) SYNNEX CORP (reduced shares -7.55%), (OMF) ONEMAIN HOLDINGS INC (added shares +7.17%), (ANTM) ANTHEM INC (reduced shares -29.66%), (COF) CAPITAL ONE FINANCIAL CORP (added shares +190.24%) and (SLM) SLM CORP (added shares +11.48%).

2014 Q4 (13 results)
KMI
buy
+4,193,877
+6.18%
$42.31
36.23% $26.98
6.18%
BHI
buy
+361,063
+0.70%
$56.07
-
0.70%
9912349D
buy
+2,833,719
+7.38%
$74.84
-
7.38%
HAL
buy
+4,141,241
+5.67%
$39.33
42.21% $22.73
5.67%
EQIX
+17.28%
+129,490
+0.99%
$219.91
257.50% $786.19
0.00%
JPM
+14.31%
+520,980
+1.14%
$62.58
381.66% $301.42
9.07%
MSFT
+5.92%
+286,218
+0.46%
$46.45
990.83% $506.69
8.28%
SCHW
+1.57%
+130,658
+0.14%
$30.19
217.46% $95.84
8.91%
VRX
-6.98%
-459,973
-2.29%
$143.11
-
30.53%
ESRX
-17.94%
-894,074
-2.64%
$84.67
9.05% $92.33
12.05%
PRI
-29.61%
-986,330
-1.86%
$54.26
396.39% $269.34
4.43%
KMR
-100.00%
-2,398,793
-7.86%
$94.15
-
0.00%
VPRT
-100.00%
-4,580,125
-8.74%
$54.79
-
0.00%
2014 Q3 (11 results)
JPM
buy
+3,641,450
+8.13%
$60.24
400.37% $301.42
8.13%
EQIX
+42.72%
+224,322
+1.71%
$206.09
281.48% $786.19
5.72%
VPRT
+26.15%
+949,435
+1.93%
$54.79
-
0.00%
VRX
+8.86%
+536,140
+2.61%
$131.20
-
32.02%
ESRX
+6.50%
+304,032
+0.80%
$70.63
30.72% $92.33
13.04%
SCHW
-0.04%
-3,228
-0.00%
$29.39
226.10% $95.84
9.09%
MSFT
-0.10%
-4,947
-0.01%
$46.36
992.95% $506.69
8.30%
PRI
-0.79%
-26,654
-0.05%
$48.22
458.56% $269.34
5.95%
KMR
-15.45%
-438,254
-1.53%
$94.15
-
0.00%
HAL
-100.00%
-70,777
-0.19%
$71.01
67.99% $22.73
0.00%
ORCL
-100.00%
-7,888,660
-11.85%
$40.53
457.93% $226.13
0.00%
2014 Q2 (10 results)
EQIX
buy
+525,047
+4.32%
$203.77
285.82% $786.19
4.32%
ESRX
+31.94%
+1,132,688
+3.17%
$69.33
33.17% $92.33
13.08%
MSFT
+21.45%
+854,783
+1.44%
$41.70
1K+% $506.69
8.14%
SCHW
+15.79%
+1,138,348
+1.24%
$26.93
255.89% $95.84
9.07%
VPRT
+14.26%
+453,030
+0.74%
$40.46
-
5.92%
VRX
+8.19%
+457,884
+2.33%
$126.12
-
30.78%
ORCL
+1.12%
+87,472
+0.14%
$40.53
457.93% $226.13
0.00%
PRI
-0.54%
-18,307
-0.04%
$47.85
462.88% $269.34
6.48%
KMR
-12.98%
-423,076
-1.35%
$78.93
-
9.03%
HAL
-98.26%
-4,003,714
-11.47%
$71.01
67.99% $22.73
0.00%
2014 Q1 (11 results)
KMR
+78.88%
+1,437,654
+4.16%
$71.67
-
9.44%
ORCL
+10.33%
+730,575
+1.21%
$40.91
452.75% $226.13
12.90%
MSFT
+0.59%
+23,218
+0.04%
$40.99
1K+% $506.69
6.60%
VPRT
-0.37%
-11,645
-0.02%
$49.22
-
6.32%
PRI
-0.40%
-13,530
-0.03%
$47.11
471.73% $269.34
6.43%
VRX
-8.52%
-520,669
-2.77%
$131.83
-
29.80%
SCHW
-9.37%
-745,336
-0.82%
$27.33
250.68% $95.84
7.96%
ESRX
-10.42%
-412,381
-1.25%
$75.09
22.96% $92.33
10.76%
HAL
-14.18%
-673,022
-1.60%
$58.89
61.40% $22.73
9.70%
1580477D
-100.00%
-2,294,480
-0.91%
$9.76
-
0.00%
CMCSK
-100.00%
-1,830,521
-3.69%
$49.88
-
0.00%
45 of 871

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.